Search

Your search keyword '"Seong, Chu-Myong"' showing total 282 results
Start Over Author "Seong, Chu-Myong"
282 results on '"Seong, Chu-Myong"'

1. Long-term follow-up results of cytarabine-containing chemotherapy for acute promyelocytic leukemia

Author

Park, Young Hoon, primary, Kim, Dae-Young, additional, Mun, Yeung-Chul, additional, Cho, Eun Kyung, additional, Lee, Jae Hoon, additional, Jo, Deog-Yeon, additional, Kim, Inho, additional, Yoon, Sung-Soo, additional, Park, Seon Yang, additional, Kim, Byoungkook, additional, Bang, Soo-Mee, additional, Kim, Hawk, additional, Min, Young Joo, additional, Park, Jae Hoo, additional, Seo, Jong Jin, additional, Moon, Hyung Nam, additional, Lee, Moon Hee, additional, Kim, Chul Soo, additional, Lee, Won Sik, additional, Chong, So Young, additional, Oh, Doyeun, additional, Zang, Dae Young, additional, Lee, Kyung Hee, additional, Hyun, Myung Soo, additional, Kim, Heung Sik, additional, Kim, Sung-Hyun, additional, Kwon, Hyukchan, additional, Kim, Hyo Jin, additional, Park, Kyung Tae, additional, Bae, Sung Hwa, additional, Ryoo, Hun Mo, additional, Choi, Jung Hye, additional, Ahn, Myung-Ju, additional, Yoon, Hwi-Joong, additional, Nam, Sung-Hyun, additional, Kim, Bong-Seog, additional, and Seong, Chu-Myong, additional

Published
2022
Full Text
View/download PDF

2. Sequential vincristine, adriamycin, dexamethasone (VAD) followed by bortezomib, thalidomide, dexamethasone (VTD) as induction, followed by high-dose therapy with autologous stem cell transplant and consolidation therapy with bortezomib for newly diagnosed multiple myeloma: results of a phase II trial

Author

Kim, Hye Jin, Yoon, Sung-Soo, Lee, Dong Soon, Sohn, Sang Kyun, Eom, Hyeon Seok, Lee, Jung Lim, Chung, Joo Seup, Kim, Kihyun, Suh, Cheolwon, Won, Jong Ho, Kim, Jin Seok, Park, Joon Seong, Kang, Hye Jin, Seong, Chu Myong, Kim, Cheol Soo, Lee, Sang Jae, and Lee, Jae Hoon

Published
2012
Full Text
View/download PDF

3. Bortezomib, thalidomide, dexamethasone induction therapy followed by melphalan, prednisolone, thalidomide consolidation therapy as a first line of treatment for patients with multiple myeloma who are non-transplant candidates: results of the Korean Multiple Myeloma Working Party (KMMWP)

Author

Eom, Hyeon-Seok, Kim, Yeo-Kyeoung, Chung, Joo-Seop, Kim, Kihyun, Kim, Hyo Jung, Kim, Ho Young, Jin, Jong-Youl, Do, Young-Rok, Oh, Suk-Joong, Suh, Cheolwon, Seong, Chu-Myong, Kim, Chul Soo, Lee, Dong Soon, and Lee, Jae Hoon

Published
2010
Full Text
View/download PDF

26. Prognostic Impact of Chromosomal Translocations in 751 Korean Patients with Primary Myelodysplastic Syndrome

Author

Suh, Koung Jin, primary, Cheong, June-Won, additional, Shin, Dong-Yeop, additional, Koh, Youngil, additional, Yoon, Sung-Soo, additional, Min, Yoo-Hong, additional, Ahn, Jae-Sook, additional, Kim, Yeo-Kyeoung, additional, Lee, Yun-Gyoo, additional, Lee, Jeong-Ok, additional, Bang, Soo-Mee, additional, Mun, Yeung-Chul, additional, Seong, Chu-Myong, additional, Park, Yong, additional, Kim, Byung-Soo, additional, Hong, Junshik, additional, Park, Jinny, additional, Lee, Jae Hoon, additional, Kim, Sung-Yong, additional, Lee, Hong Ghi, additional, Kim, Hyeoung-Joon, additional, and Kim, Inho, additional

Published
2016
Full Text
View/download PDF

29. Loss of CD26 Protease Activity in Recipient Mice during Hematopoietic Stem Cell Transplantation Results in Improved Transplant Efficiency

Author

Yoo, Eunsun, Paganessi, Laura A., Alikhan, Wasfia A., Paganessi, Elizabeth A., Hughes, Frank, Fung, Henry C., Rich, Elizabeth, Seong, Chu Myong, and Christopherson, Kent W.

Subjects
Mice, Inbred C57BL, Dipeptidyl-Peptidase IV Inhibitors, Mice, Mice, Congenic, Cell Movement, Dipeptidyl Peptidase 4, Hematopoietic Stem Cell Transplantation, Animals, Flow Cytometry, Oligopeptides, Article, Biomarkers, Hematopoiesis
Abstract

A firm understanding of the biology of hematopoietic stem and progenitor cell (HSC/HPC) trafficking is critical to improve transplant efficiency and immune reconstitution during hematopoietic stem cell transplantation (HSCT). Our earlier findings suggested that suppression of CD26 (dipeptidyl peptidase IV) proteolytic activity in the donor cell population can be utilized as a method for increasing transplant efficiency. However, factors in the recipient should not be overlooked, given the potential for the bone marrow (BM) microenvironment to regulate HSCT.We first evaluated CD26 expression and then investigated the effects of the CD26 inhibitor diprotin A and the absence of CD26 (CD26-/-) in recipient mice on HSC/HPC homing and engraftment using an in vivo congenic mouse model of HSCT.A significant increase in donor cell engraftment into the peripheral blood (PB), and to a lesser extent homing into the BM, was observed in CD26-/- mice or CD26 inhibitor-treated mice. Increased PB engraftment of CD26-/- mice was significant at 3 and 6 months, but not 1 month, after transplant. It was noted that the increased homing was statistically greater with donor cell manipulation (CD26-/- donor cells) than with recipient manipulation (CD26-/- recipient mice). Conversely, donor and recipient manipulation both worked well to increase PB engraftment at 6 months.These results provide preclinical evidence of CD26, in the HSCT recipient, as a major regulator of HSC/HPC engraftment with minor effects on HSC/HPC homing and suggest the potential use of CD26 inhibitors in HSCT patients to improve transplant efficiency.

Published
2012

41. Restrospective Multicenter Study Evaluating Efficacy and Safety of Dasatinib and Nilotinib in Patients with Imatinib-Resistant or –intolerant Chronic Myeloid Leukemia in Chronic Phase: Korean CML Working Party

Author

Lee, Jeong-Ok, primary, Kim, Inho, additional, Chung, Joo-Seop, additional, Kim, Yeo-Kyeoung, additional, Yhim, Ho-Young, additional, Kim, Dae-Young, additional, Do, Young-Rok, additional, Seong, Chu-Myong, additional, Nam, Seung-Hyun, additional, Kim, Sung-Hyun, additional, Lee, Jae-Hoon, additional, Park, Jinny, additional, Kim, Jin Seok, additional, Min, Yoo-Hong, additional, Sohn, Sang Kyun, additional, Joo, Young Don, additional, Bae, Sung-Hwa, additional, Oh, Sukjoong, additional, Zang, Dae Young, additional, Lee, Hong Ghi, additional, Yoon, Sung-Soo, additional, and Park, Seonyang, additional

Published
2012
Full Text
View/download PDF

49. Sequential vincristine, adriamycin, dexamethasone (VAD) followed by bortezomib, thalidomide, dexamethasone (VTD) as induction, followed by high-dose therapy with autologous stem cell transplant and consolidation therapy with bortezomib for newly diagnosed multiple myeloma: results of a phase II trial

Author

Kim, Hye Jin, primary, Yoon, Sung-Soo, additional, Lee, Dong Soon, additional, Sohn, Sang Kyun, additional, Eom, Hyeon Seok, additional, Lee, Jung Lim, additional, Chung, Joo Seup, additional, Kim, Kihyun, additional, Suh, Cheolwon, additional, Won, Jong Ho, additional, Kim, Jin Seok, additional, Park, Joon Seong, additional, Kang, Hye Jin, additional, Seong, Chu Myong, additional, Kim, Cheol Soo, additional, Lee, Sang Jae, additional, and Lee, Jae Hoon, additional

Published
2011
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results